Projects

View all projects

83 results
  • @OBEDIS

    Finished
    Duration:
    01/2018
    -
    01/2019

    Obesity is a problem that represents a significant health and economic burden in Europe and throughout the world. The...

  • MEDIMACS

    Finished
    Duration:
    01/2018
    -
    05/2022

    Coronary atherosclerosis is a leading cause of mortality and disability worldwide. Continuous efforts are needed to...

  • TransMic

    Finished
    Duration:
    01/2018
    -
    05/2022

    Important gaps remain in our understanding how diet and the composition of the gut microbiota influence the function of...

  • DiGuMet

    Finished
    Duration:
    01/2018
    -
    05/2022

    The human gut microbiota has been linked with incidence and progression of noncommunicable diseases and their...

  • MICRODIET

    Finished
    Duration:
    12/2017
    -
    12/2021

    Metabolic disorders such as obesity and type 2 diabetes (T2D) represent a growing unmet clinical need. Accumulating...

  • BioFN

    Finished
    Duration:
    11/2017
    -
    10/2020
    Background

    Childhood obesity is a rapidly growing problem in many countries across the world. Weight loss programs have...

  • BioNUGUT

    Finished
    Duration:
    09/2017
    -
    11/2020
    Background and aim

    In recent decades, nutritional science and biomedicine have made enormous progress in the development...

  • CABALA_Diet & Health

    Finished
    Duration:
    06/2017
    -
    05/2021
    Background and aim

    Bile acids (BA) through G protein-coupled bile acid receptor 1 (GPBAR1 or TGR5) and nuclear receptors...

  • OXYGENATE

    Finished
    Duration:
    06/2017
    -
    08/2021
    Background and aim 

    There is an urgent need to find reliable early biomarkers of the cardiometabolic syndrome (CardMetS)...

  • VALID

    Finished
    Duration:
    05/2017
    -
    09/2019
    Background and aim

    The VALID project aims to validate plasma valerolactones as stable biomarkers of catechin- and...

  • FAME

    Finished
    Duration:
    05/2017
    -
    01/2021
    Background and aim

    FAME aimed to a) identify novel lipidomics biomarkers as biomarkers of fatty acid status and of future...

  • SALIVAGES

    Finished
    Duration:
    05/2017
    -
    04/2020
    Background and aim

    Recent findings convincingly demonstrate that Advanced Glycation End Products (AGEs) are modifiable by...